ENDRA Life Sciences Reports Quarterly Results for June 30, 2026

What Happened
ENDRA Life Sciences (NDRA) announced its financial results for the quarter ended June 30, 2026 via a press release that was furnished with a Form 8-K filed on August 17, 2026. The press release is provided as Exhibit 99.1 to the filing. The Form 8-K itself notifies investors that the company has released its quarterly results; details and figures are contained in the referenced press release.

Key Details

• Filing date: August 17, 2026 (Form 8-K).
• Reporting period: quarter ended June 30, 2026.
• Exhibit provided: Press Release dated August 17, 2026 (Exhibit 99.1).
• Technical exhibit: Inline XBRL cover page included (Exhibit 104).

Why It Matters
This filing signals that ENDRA has released its latest quarterly earnings information—important for investors tracking revenue, net income/loss, cash runway, and any guidance. The 8-K itself simply furnishes the press release; review Exhibit 99.1 (or the company’s investor relations page) for the specific financial figures and management commentary that could influence the stock price or investment decisions.